Jack Trottier

@Birchview Capital, Lp

Latest period2024 - Q3

Reported2mo 5d ago

Managed Assets$115.222M

Total holdings61

Assets growth rate6.73%

Assets growth rate (2-Q avg)-2.56%

Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Birchview Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 61 positions.

Assets under management

The assets under management (AUM) of Birchview Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 115.222M in assets, with a quarterly growth rate of 6.73% and a 2-quarter average growth rate of -2.56%. The portfolio is managed by Jack Trottier, and others.

Portfolio holdings

Current New Position Increased Decreased Exited

Investment	Portfolio %	Reported Value	Recent Activity
ACADAcadia Pharmaceuticals Inc Recent Activity Increased 59.91%	5.35%	$6.158M 400,400 shares@ $15.38 avg price	Increased 59.91%
PRTAProthena Corp Plc Recent Activity Increased 2.95%	3.05%	$3.506M 209,574 shares@ $16.73 avg price	Increased 2.95%
TVTXTravere Therapeutics Inc Recent Activity Increased 21.32%	1.8%	$2.071M 148,000 shares@ $13.99 avg price	Increased 21.32%
DCGODocgo Inc Recent Activity Increased 11.96%	1.49%	$1.71M 515,000 shares@ $3.32 avg price	Increased 11.96%
CSTLCastle Biosciences Inc Recent Activity Increased 70.59%	1.44%	$1.654M 58,000 shares@ $28.52 avg price	Increased 70.59%
ATECAlphatec Holdings Inc Recent Activity Increased 125%	0.96%	$1.101M 198,000 shares@ $5.56 avg price	Increased 125%
KALVKalvista Pharmaceuticals Inc Recent Activity Increased 78.27%	0.83%	$949,560 82,000 shares@ $11.58 avg price	Increased 78.27%
INBXInhibrx Biosciences Inc Recent Activity Increased 165.16%	0.44%	$502,843 32,110 shares@ $15.67 avg price	Increased 165.16%
CHRSCoherus Biosciences Inc Recent Activity Increased 37.78%	0.34%	$386,880 372,000 shares@ $1.04 avg price	Increased 37.78%